Oxford Biomedica plc (LON:OXB), a global quality and innovation-led cell and gene therapy CDMO, has announced the date of its Capital Markets Day and participation at upcoming investor conferences.
Capital Markets Day
OXB will hold its Capital Markets Day at the London Stock Exchange Group (LSEG) headquarters on 2 June 2026. Further details, including the agenda and registration information, will be provided in due course.
Upcoming Investor Conferences
UBS European Healthcare Conference
Date: 3 – 4 March 2026
Location: London, UK
Berenberg UK Corporate Conference
Date: 17- 19 March 2026
Location: Watford, UK
25th Annual Needham Virtual Healthcare Conference
Date: 13 – 16 April 2026
Location: Virtual
Berenberg Midsummer Midcaps Conference
Date: 4 – 5 June 2026
Location: Ascot, UK
Investors attending any of the above conferences who would like to meet with Oxford Biomedica are welcome to contact the Company’s IR team via [email protected].
Live webcasts and recordings of presentations, where available, will be accessible under ‘Results, Reports, Presentations & Webcasts’ in the Investor Relations section of OXB’s website at www.oxb.com.
FY 2025 Preliminary Results
As previously announced, OXB will report its preliminary results for the twelve months ended 31 December 2025 on 26 March 2026. OXB’s management team, led by Dr. Frank Mathias, Chief Executive Officer, Dr. Lucy Crabtree, Chief Financial Officer, and Dr. Sébastien Ribault, Chief Business Officer, will host a virtual analyst briefing at 13:00 GMT / 08:00 ET. To register, please contact [email protected].
For details of other upcoming financial events, please refer to the Company’s investor calendar at https://oxb.com/investor-events/.
